Vikas Bhambhani, MD

Board Certification
•Clinical Genetics - American Board of Medical Genetics and Genomics
•Medical Biochemical Genetics - American Board of Medical Genetics and Genomics
•Pediatrics - American Board of Pediatrics

Medical Education
•MBBS - Maulana Azad Medical College, New Delhi, India

Residency/Fellowship
•Residency - New York Medical College, Valhalla, NY
•Fellowship - National Institutes of Health, Bethesda, MD
•Fellowship - National Institutes of Health, Bethesda, MD

Research :Current Projects
2020- Physician Investigator, “Single Patient Expanded Access Use of EPI-743 (Vatiquinone)”PTC Therapeutics, Inc.
2020- Site Principal Investigator, “Cerliponase alfa Observational Study”BioMarin Pharmaceutical, Inc.
2020- Site Principal Investigator, “LAL Deficiency Registry”BioMarin Pharmaceutical, Inc.
2019- Site Principal Investigator, “MPS VI Clinical Surveillance Program (CSP)”BioMarin Pharmaceutical Inc.
2018- Site Principal Investigator, “Rare Disease Registries: Fabry, Gaucher, MPS I and Pompe”Sanofi Genzyme
2015- Site Principal Investigator, “Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients with Hunter Syndrome (MPS II)”Shire Human Genetic Therapies, Inc.
2015- Site Principal Investigator, “Gaucher Disease Outcome Survey (GOS)” Shire Human Genetic Therapies, Inc.
2014- Site Principal Investigator, “Morquio A Registry Study (MARS)”BioMarin Pharmaceutical Inc.

Special Interests:Mitochondrial disorder, Leukodystrophy, Refractory epilepsy and Neurotransmitter deficiency.